Asensus Surgical, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 12 rows in 2021. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2021-07-01: Reporting owner Biffi Andrea; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2021-06-30: Reporting owner Starling William N JR; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2021-06-30: Reporting owner LAVIOLETTE PAUL A; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2021-06-30: Reporting owner HSIAO JANE PH D; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2021-07-01 | Biffi Andrea Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +35,479 35,479 owned after | $2.93 exercise price | 2021-07-02 | |
| 2021-06-30 | Starling William N JR Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,310 4,310 owned after | $3.17 exercise price | 2021-07-02 | |
| 2021-06-30 | LAVIOLETTE PAUL A Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,025 10,025 owned after | $3.17 exercise price | 2021-07-02 | |
| 2021-06-30 | HSIAO JANE PH D Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,748 3,748 owned after | $3.17 exercise price | 2021-07-02 | |
| 2021-06-30 | Biffi Andrea Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,748 3,748 owned after | $3.17 exercise price | 2021-07-02 | |
| 2021-06-09 | Fernando Anthony C. J. Director, Officer (President and CEO) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −183,338 366,662 owned after | $0.82 exercise price | 2021-06-10 | |
| 2021-03-31 | LAVIOLETTE PAUL A Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,440 8,440 owned after | $3.25 exercise price | 2021-04-02 | |
| 2021-03-31 | Biffi Andrea Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,155 3,155 owned after | $3.25 exercise price | 2021-04-02 | |
| 2021-03-31 | HSIAO JANE PH D Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,155 3,155 owned after | $3.25 exercise price | 2021-04-02 | |
| 2021-03-31 | Starling William N JR Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,628 3,628 owned after | $3.25 exercise price | 2021-04-02 | |
| 2021-02-08 | Shameze Rampertab Officer (EVP, Chief Financial Officer) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +73,078 73,078 owned after | $4.21 exercise price | 2021-02-08 | |
| 2021-02-08 | Fernando Anthony C. J. Director, Officer (President and CEO) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +868,161 868,161 owned after | $4.21 exercise price | 2021-02-08 |